La. Woman Says Ozempic, Mounjaro Makers Failed to Warn of Severe Gastrointestinal Events



DOCUMENTS
  • Complaint


LAKE CHARLES, La. — A Louisiana woman has sued Novo Nordisk and Eli Lilly & Co., accusing them of failing to warn that their injectable type 2 diabetes drugs Ozempic and Mounjaro can cause paralyzed stomach or inflammation of the stomach and intestines.

In an Aug. 2 complaint filed in the U.S. District Court for the Western District of Louisiana, Jacklyn Bjorklund says defendants “have downplayed the severity of the gastrointestinal events” caused by the GLP-1 receptor drugs and that they carry a risk of gastroparesis or gastroenteritis.

Gastroparesis affects normal muscle movement in the stomach, hampering its ability …

FIRM NAMES
  • Morgan & Morgan





UPCOMING CONFERENCES




HarrisMartin's New Jersey Asbestos Litigation Conference

March 01, 2024 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS



HarrisMartin's Webinar Series: Suboxone (Buprenorphine/Naloxone) Film Marketing, Sales Practices and Products Litigation - MDL No. 3092

December 18, 2023

MORE DETAILS